The company was granted temporary listing approval by the EGX Listing Committee in March with issued capital of EGP 5 billion.
The planned capital injection aims to finance an ambitious expansion strategy in Egypt and select Gulf markets, strengthening the company’s presence in the healthcare sector locally and regionally.
